CFA
GMAB icon

Carroll Financial Associates’s Genmab GMAB Stock Holding History

Carroll Financial Associates’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$0 Hold
11
– – ﹤0.01% 1738
2021
Q3 		$0 Buy
+11
New +$494 ﹤0.01% 1828
2021
Q2 		– Sell
-300
Closed -$9K – 1743
2021
Q1 		$9K Buy
+300
New +$11.3K ﹤0.01% 1235
2020
Q2 		– Sell
-162
Closed -$3K – 1579
2020
Q1 		$3K Hold
162
– – ﹤0.01% 1230
2019
Q4 		$3K Buy
+162
New +$3.54K ﹤0.01% 1319

Other funds holding GMAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carroll Financial Associates's GMAB Position: Q4 2021 in Review

Carroll Financial Associates held its Genmab (GMAB) position steady in Q4 2021 at 11 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1738.

Carroll Financial Associates first reported a position in GMAB in Q4 2019 and has held it in 5 quarters since. The position peaked at $9K in Q1 2021. 212 funds tracked by Wall St. Rank hold GMAB as of Q4 2021.

  • Carroll Financial Associates held 11 shares of Genmab worth $0 as of Q4 2021.
  • Carroll Financial Associates left its Genmab share count unchanged in Q4 2021.
  • Genmab made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1738 holding.
  • Carroll Financial Associates first reported a position in Genmab in Q4 2019 and has held it in 5 quarters since.
  • Carroll Financial Associates's Genmab position peaked at $9K in Q1 2021.
  • 212 funds tracked by Wall St. Rank held Genmab as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.